Royal Bank Of Canada Lexaria Bioscience Corp. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Royal Bank Of Canada holds 7,283 shares of LEXX stock, worth $10,706. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,283
Previous 7,283
-0.0%
Holding current value
$10,706
Previous $22,000
31.82%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LEXX
# of Institutions
27Shares Held
1.47MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY460KShares$676,2000.01% of portfolio
-
Invenomic Capital Management LP Boston, MA411KShares$603,7740.04% of portfolio
-
Geode Capital Management, LLC Boston, MA167KShares$245,0180.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA127KShares$187,3260.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL60.6KShares$89,1400.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $8.75M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...